← Back to Search

Vaccination Games for Vaccine Education

N/A
Recruiting
Led By ANGELA CHEN, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up t2 (occurs two months after completion of the intervention)
Awards & highlights

Summary

This trial will explore ways to make sure kids get the HPV and COVID-19 vaccines they need, especially those from vulnerable backgrounds.

Who is the study for?
This trial is for parents or caregivers of children aged 11-14 who haven't had their first HPV or COVID-19 vaccine dose. The child must be able to speak and read English, and both the parent and child should be undecided or not planning on getting these vaccines.
What is being tested?
The study tests 'vaccination games' designed to increase confidence in vaccines among underserved youth. It focuses on improving uptake rates for the HPV and COVID-19 vaccines by engaging with children through educational gameplay.
What are the potential side effects?
Since this trial involves educational games rather than medical interventions, there are no direct side effects like those associated with drugs or medical procedures. However, it's important to monitor any misinformation that could affect vaccine confidence.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~t0 (occurs after consenting and before assigning to different study conditions); t1 (occurs immediately post intervention);t2 (occurs two months after completion of the intervention)
This trial's timeline: 3 weeks for screening, Varies for treatment, and t0 (occurs after consenting and before assigning to different study conditions); t1 (occurs immediately post intervention);t2 (occurs two months after completion of the intervention) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Intention to vaccinate the children against HPV
Participant satisfaction with the project
Percentage of eligible individuals agreeing to participate
+2 more
Secondary study objectives
Children receives the first dose of HPV vaccine

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: HPV game groupExperimental Treatment1 Intervention
parent-child dyads receive HPV game intervention
Group II: COVID game groupExperimental Treatment1 Intervention
parent-child dyads receive COVID game intervention
Group III: Usual careActive Control1 Intervention
parent-child dyads receive usual care (no intervention)

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
193 Previous Clinical Trials
669,055 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
131 Patients Enrolled for Vaccine-Preventable Diseases
ANGELA CHEN, PhDPrincipal InvestigatorMichigan State University
1 Previous Clinical Trials
131 Total Patients Enrolled
1 Trials studying Vaccine-Preventable Diseases
131 Patients Enrolled for Vaccine-Preventable Diseases

Media Library

HPV game group Clinical Trial Eligibility Overview. Trial Name: NCT05984849 — N/A
Vaccine-Preventable Diseases Research Study Groups: HPV game group, COVID game group, Usual care
Vaccine-Preventable Diseases Clinical Trial 2023: HPV game group Highlights & Side Effects. Trial Name: NCT05984849 — N/A
HPV game group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05984849 — N/A
~16 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top